| Nome do produto |
Sitagliptin |
| Sinônimos |
(3R)-3-Amino-1-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; 1,2,4-Triazolo(4,3-a)pyrazine, 7-((3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl)-5,6,7,8-tetrahydor-3-(trifluoromethyl)-; Sitagliptin Intermediate; (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine; (3S)-3-amino-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)butan-1-one; Sitagliptin Base; Sitagliptine; Sitagliptin free base; SIT-B |
| Fórmula molecular |
C16H15F6N5O |
| Peso Molecular |
407.3136 |
| InChI |
InChI=1/C16H15F6N5O/c17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22/h4,6,9H,1-3,5,7,23H2/t9-/m0/s1 |
| CAS Registry Number |
486460-32-6;790712-60-6 |
| Estrutura Molecular |
|
| Densidade |
1.614g/cm3 |
| Ponto de ebulição |
529.905°C at 760 mmHg |
| índice de refração |
1.59 |
| O ponto de inflamação |
274.277°C |
|
